Progress in comprehensive treatment of advanced hepatocellular carcinoma
	    		
		   		
		   			
		   		
	    	
    	 
    	10.3969/j.issn.1000-8179.2018.21.899
   		
        
        	
        		- VernacularTitle:晚期肝癌综合治疗进展
 
        	
        	
        	
        		- Author:
	        		
		        		
		        		
			        		Yan CONG
			        		
			        		
			        		
			        			1
			        			
			        		
			        		
			        		
			        		
			        		;
		        		
		        		
		        		
			        		Xiaoxuan TU
			        		
			        		;
		        		
		        		
		        		
			        		Wei WU
			        		
			        		;
		        		
		        		
		        		
			        		Zhou TONG
			        		
			        		;
		        		
		        		
		        		
			        		Hangyu ZHANG
			        		
			        		;
		        		
		        		
		        		
			        		Lulu LIU
			        		
			        		;
		        		
		        		
		        		
			        		Yi ZHENG
			        		
			        		;
		        		
		        		
		        		
			        		Peng ZHAO
			        		
			        		;
		        		
		        		
		        		
			        		Weiqin JIANG
			        		
			        		;
		        		
		        		
		        		
			        		Weijia FANG
			        		
			        		
		        		
		        		
		        		
		        		
		        			
			        		
			        		Author Information
			        		
		        		
		        		
			        		
			        		
			        			1. 浙江大学附属第一医院肿瘤细胞生物治疗中心 杭州市310000
			        		
		        		
	        		
        		 
        	
        	
        	
        	
        		- Keywords:
        			
	        			
	        				
	        				
			        		
				        		hepatocellular carcinoma;
			        		
			        		
			        		
				        		comprehensive treatment;
			        		
			        		
			        		
				        		targeted therapy;
			        		
			        		
			        		
				        		immunotherapy
			        		
			        		
	        			
        			
        		
 
        	
            
            
            	- From:
	            		
	            			Chinese Journal of Clinical Oncology
	            		
	            		 2018;45(21):1100-1103
	            	
            	
 
            
            
            	- CountryChina
 
            
            
            	- Language:Chinese
 
            
            
            	- 
		        	Abstract:
			       	
			       		
				        
				        	In recent years, the incidence of hepatocellular carcinoma (HCC) has risen year by year, leading to a high mortality rate. At present, surgical treatment is the major cure for HCC, and in general, HCC is diagnosed at late stages. Due to the heterogeneity of HCC and different sensitivities to drugs, the treatment efficacy of advanced HCC is poor. In this paper, we retrospectively analyzed the prog-ress of HCC treatments and reviewed important progression, which provides new view for the clinical improvement of the total surviv-al of patients with HCC.